相关实验视频
Updated: May 21, 2025

00:07
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.2K
miR-103通过向FOXP1促进食道状细胞癌转移
Min Huang1, Jun Cai1, Hai Zeng1
1Department of Oncology, The First People's Hospital of Jingzhou City, Jingzhou, China.
Nucleosides, nucleotides & nucleic acids
|March 21, 2025
概括
微RNA-103 (miR-103) 在食道状细胞癌 (ESCC) 中升高,通过向FOXP1促进癌细胞转移,并可能作为预后生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 食道状细胞癌 (ESCC) 是一种致命的消化道癌.
- 已知微RNAs (miRNAs) 在各种癌症中发挥作用.
- 在ESCC病原体中的miR-103的特定作用需要进一步阐明.
研究的目的:
- 调查miR-103在ESCC发展中的作用.
- 探索ESCC中miR-103作用的潜在分子机制.
- 评估miR-103作为ESCC的潜在预后生物标志物.
主要方法:
- 实时定量聚合酶连锁反应 (RT-qPCR) 用于测量miR-103的表达.
- 特兰斯韦尔测试用于评估细胞迁移和侵入.
- 双 luciferase 记者基因测定证实FOXP1 是 miR-103.3 的目标.
主要成果:
- 在ESCC组织和细胞系中,miR-103的表达显著上调.
- 高MIR-103水平与ESCC患者的预后不佳相关.
- 减少miR-103表达抑制了ESCC细胞的增殖,迁移和入侵.
- miR-103直接准头盒蛋白1 (FOXP1) 的目标.
结论:
- miR-103可以作为ESCC的有价值的预后生物标志物.
- miR-103通过向FOXP1.3来促进ESCC细胞转移.
- miR-103为ESCC治疗提供了一个潜在的新型治疗点.
相关概念视频
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K

